On August 7, 2023, the Board of Directors of Allarity Therapeutics, Inc. received the resignation of Mr. Robert Oliver as director of the Company, including his position on each Board committee on which he was appointed to, effective immediately. Mr. Oliver?s resignation is for personal reasons and not due to any disagreement with the Company?s management team or the Company?s Board on any matter relating to the operations, policies or practices of the Company or any issues regarding the Company?s accounting policies or practices. To fill the vacancy on the Board committees as a result of Mr. Oliver?s resignation, the Board appointed Dr. Laura Benjamin as a member of the Audit Committee and Compensation Committee of the Board, effective as of August 7, 2023.

Dr. Benjamin was previously appointed as an independent director and is also a member of the Nominating and Governance Committee of the Board since August 1, 2023.